Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery.
about
Ultrasound contrast agents.MR-Guided Delivery of Hydrophilic Molecular Imaging Agents Across the Blood-Brain Barrier Through Focused UltrasoundDiagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubblesWashout Ratio in the Hepatic Vein Measured by Contrast-Enhanced Ultrasonography to Distinguish Between Inflammatory and Noninflammatory Hepatic Disorders in Dogs.Targeting activated hepatic stellate cells (aHSCs) for liver fibrosis imagingNanobubbles: a promising efficient tool for therapeutic delivery.Value of three-section contrast-enhanced transrectal ultrasonography in the detection of prostate cancer.Status and trends in the development of clinical diagnostic agents.Advances in the clinical translation of nanotechnology.A new approach to transfect NF-κB decoy oligodeoxynucleotides into the periodontal tissue using the ultrasound-microbubble method.Construction of ultrasonic nanobubbles carrying CAIX polypeptides to target carcinoma cells derived from various organs.Ultrasound microbubble-mediated transfection of NF-κB decoy oligodeoxynucleotide into gingival tissues inhibits periodontitis in rats in vivo.Conjugated Polymer Nanoparticles for Bioimaging.Targeting of microbubbles: contrast agents for ultrasound molecular imaging.Alzheimer’s Disease, Brain Injury, and C.N.S. Nanotherapy in Humans: Sonoporation Augmenting Drug Targeting.Microfluidic production of nanoscale perfluorocarbon droplets as liquid contrast agents for ultrasound imaging.A methodological approach for quantifying and characterizing the stability of agitated saline contrast: implications for quantifying intrapulmonary shunt.Contrast-enhanced ultrasound of malignant liver lesions.Influence of contrast-enhanced ultrasound administration setups on microbubble enhancement: a focus on pediatric applications.Nanobubble-embedded inorganic 808 nm excited upconversion nanocomposites for tumor multiple imaging and treatment.Cavitation-threshold Determination and Rheological-parameters Estimation of Albumin-stabilized Nanobubbles.A Narrative Review on Contrast-Enhanced Ultrasound in Aortic Endograft Endoleak Surveillance
P2860
Q28077669-8F547AAB-3F80-4EF8-9AC0-A32A38E79219Q28817563-BA4983E3-351D-4CA8-A227-6F90F1546394Q28829750-79DB9F7F-AA5F-4940-92BF-94C57AE0E038Q30356064-FF050E20-0248-40D7-9637-761A5135603BQ30395463-4B34EFA3-B190-4E3F-B853-FE1708B0232BQ38697378-72B8FF4D-E293-4071-AF11-B07D687CD6EDQ38967668-6BD8F6F0-97B4-447B-AA8B-73A1A576742EQ38995734-9CE20C50-FC43-4858-9E25-B7F8485207D3Q39130471-DF57591E-F29C-4C8A-85B6-7D1B44300CA5Q41070881-95D87224-F403-492B-8324-6B2780C02676Q42233933-4E59D948-6A77-4E17-957F-5B53B5EB2EDDQ43808143-5162262E-1C11-49CD-9582-3CD902415B74Q47138211-49A68B10-EA46-4E8C-B187-F900D753C9BEQ47234214-BBAA43D7-6D1C-40EE-8D38-DF20055AD586Q47408666-0EB809C3-1E53-4C85-9A37-5AAFA778E279Q47652206-D8B915EA-3ABF-42EB-9370-6B0ED6055D9FQ48179216-0CE55501-F0B5-4518-B43D-E5F161A70E93Q48378939-E02C83AF-3716-48C5-8D1C-B60F35177945Q50143311-A668686A-1D35-4599-8547-4B7C2F022314Q55035230-D89F2339-4C1E-4647-AB58-3A6D3501C527Q55438529-10D1F645-4A69-4F53-A2F8-FBC2AD3A7BA5Q57166329-A09D7535-C5A2-4339-B797-7A66A5C51F79
P2860
Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery.
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery
@nl
Evolution of contrast agents f ...... asound-mediated drug delivery.
@ast
Evolution of contrast agents f ...... asound-mediated drug delivery.
@en
type
label
Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery
@nl
Evolution of contrast agents f ...... asound-mediated drug delivery.
@ast
Evolution of contrast agents f ...... asound-mediated drug delivery.
@en
prefLabel
Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery
@nl
Evolution of contrast agents f ...... asound-mediated drug delivery.
@ast
Evolution of contrast agents f ...... asound-mediated drug delivery.
@en
P2093
P2860
P3181
P356
P1476
Evolution of contrast agents f ...... asound-mediated drug delivery.
@en
P2093
Dennis Doleschel
Fabian Kiessling
Vera Paefgen
P2860
P3181
P356
10.3389/FPHAR.2015.00197
P407
P577
2015-09-15T00:00:00Z